REFERENCES
- Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol. 2010;25:1409–1418.
- Servais A, Fremeaux-Bacchi V, Lequintrec M, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2007;44:193–199.
- Cochat P, Fargue S, Mestrallet G, et al. Disease recurrence in paediatric renal transplantation. Pediatr Nephrol. 2009;24:2097–2108.
- Tarshish P, Bernstein J, Tobin JN, Edelmann CM Jr. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone: a report of the International Study of Kidney Disease in Children. Pediatr Nephrol. 1992;6:123–30.
- Smith KD, Alpers CE. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens. 2005;14:396–403.
- Roumenina l, Servais A, Fakhouri F, et al. Acquired and hereditary complement dysregulation in patients with C3 glomerulopathy [abstract]. Mol Immunol. 2009;46:2864.
- Pickering MC, Cook HT. Translational minireview series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol. 2008;151:210–230.
- Levy M, Gubler MC, Sich M, Beziau A, Habib R. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (type I MPGN). Clin Immunol Immunopathol. 1978;10:477–492.
- Appel GB, Cook HT, Hageman G, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol. 2005;16:1392–1403.
- Sotsiou F, Dimitriadis G, Liapis H. Diagnostic dilemmas in atypical postinfectious glomerulonephritis. Semin Diagn Pathol. 2002;19:146–159.
- Hébert MJ, Takano T, Papayianni A, et al. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant. 1998;13:2799–2803.
- Bircan Z, Toprak D, Kilicaslan I, et al. Factor H deficiency and fibrillary glomerulopathy. Nephrol Dial Transplant. 2004;19:727–730.
- Neary J, Dorman A, Campbell E, Keogan M, Conlon P. Familial membranoproliferative glomerulonephritis type III. Am J Kidney Dis. 2002;40:E1.
- Neary JJ, Conlon PJ, Croke D, et al. Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1. J Am Soc Nephrol. 2002;13:2052–2057.
- Józsi M, Zipfel PF. Factor H family proteins and human diseases. Trends Immunol. 2008;29:380–387.
- Fakhouri F, Frémeaux-Bacchi V, Noël LH, Cook HT, Pickering MC. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6:494–499.
- Motoyama O, Sakai K, Ohashi Y, et al. Membranoproliferative glomerulonephritis in a girl and her mother. Clin Exp Nephrol. 2009;13:77–80.
- Licht C, Fremeaux-Bacchi V. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis. Thromb Haemost. 2009;101:271–278.
- Wagner E, Frank MM. Therapeutic potential of complement modulation. Nat Rev Drug Discov. 2010;9:43–56.